Company Description
You see, UCB concerns itself primarily with pharmaceuticals. The company has exited the chemicals business and is focusing on its...
Key UCB Financials
| Company Type | Public - Euronext Brussels: UCB Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $3,328.6 |
| 2006 Employees | 8,477 |
More UCB Financials (3 pages)
Rankings
- BEL20
- Euronext 100
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about UCB's competition across multiple industries
Top UCB Competitors
Sponsored Links
The Business Directory
UCB Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, Executive Committee, and CEO | Roch F. Doliveux | Network | E-mail |
| EVP Global Operations | William (Bill) Robinson | Network | E-mail |
| VP and CIO | Vincent Damien | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current UCB News
- BINDING PROTEINS, INCLUDING ANTIBODIES, ANTIBODY DERIVATIVES AND ANTIBODY FRAGMENTS, THAT SPECIFICALLY BIND CD154 AND USES THEREOF [PCT Biblio Info] (02 Dec 2008 08:43:00 EST)
- BICYCLIC AND HETEROBICYCLIC DERIVATIVES,PROCESSES FOR PREPARING THEM AND THEIR USES [PCT Biblio Info] (02 Dec 2008 08:40:00 EST)
- BICYCLIC AND HETEROBICYCLIC DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES [PCT Biblio Info] (02 Dec 2008 08:40:00 EST)
Sponsored Opportunity
